Trump, Golden Dome
Digest more
2don MSN
South Korea is home to about 28,500 U.S. troops known as U.S. Forces Korea. Cost sharing only became a feature of the alliance in 1991, when Seoul agreed to share some of the burden of stationing U.S.
South Korea pledged on Wednesday more support measures for key export industries such as biopharmaceuticals and autos, as U.S. President Donald Trump's sweeping tariffs weigh on the trade-reliant economy.
6h
The Chosun Ilbo on MSNTrump drug pricing order opens doors for Korean biosimilarsA sweeping executive order signed by U.S. President Donald Trump to slash domestic drug prices has drawn fierce opposition from American pharmaceutical firms, which warn the move could cost the industry up to $1 trillion in revenue over the next decade.
2h
Yonhap News Agency on MSN(LEAD) S. Korea's exports to U.S., China likely to decline further over U.S. tariff scheme: trade chiefSouth Korea's exports to the United States and China are expected to decline further in May, as the impact of the Donald Trump administration's sweeping tariff scheme has begun to materialize, the country's top trade official said Wednesday.
South Korea's government pledged on Wednesday more support measures for key export industries, including the biopharmaceutical and auto sectors, which are expected to be hit by U.S. President Donald Trump's sweeping tariffs.
3d
Irish Star on MSNTrump downplays outrageous $45M cost of North Korea-style birthday parade—it's 'peanuts'The event will be held on June 14, which is also Trump's 79th birthday, as part of the Army's 250th anniversary celebrations
5dOpinion
Korea JoongAng Daily on MSNKorea must navigate Trump’s second term with strategic patience and pragmatismAs Korea navigates the uncertainty, volatility, and unpredictability that will define the remaining three years of Trump’s second term, a strategic posture anchored in flexibility, creativity, and sensitivity is essential.
South Korea's government pledged more support measures on Wednesday for key export industries, including the biopharmaceutical and auto sectors, which are expected to be hit by U.S. President Donald Trump's sweeping tariffs.